Patents Assigned to CMP Development LLC
  • Spironolactone aqueous compositions
    Patent number: 11491166
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: November 8, 2022
    Assignee: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone Aqueous Compositions
    Publication number: 20220313709
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Application
    Filed: June 16, 2022
    Publication date: October 6, 2022
    Applicant: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone Aqueous Compositions
    Publication number: 20220305032
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Application
    Filed: June 16, 2022
    Publication date: September 29, 2022
    Applicant: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone aqueous compositions
    Patent number: 11395828
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: July 26, 2022
    Assignee: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone aqueous compositions
    Patent number: 11389461
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: July 19, 2022
    Assignee: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone Aqueous Compositions
    Publication number: 20210353646
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Application
    Filed: July 23, 2021
    Publication date: November 18, 2021
    Applicant: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone Aqueous Compositions
    Publication number: 20210346404
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Application
    Filed: July 23, 2021
    Publication date: November 11, 2021
    Applicant: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone Aqueous Compositions
    Publication number: 20210085694
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Application
    Filed: December 4, 2020
    Publication date: March 25, 2021
    Applicant: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone aqueous compositions
    Patent number: 10888570
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: January 12, 2021
    Assignee: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone Aqueous Compositions
    Publication number: 20200276212
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Application
    Filed: May 19, 2020
    Publication date: September 3, 2020
    Applicant: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone aqueous compositions
    Patent number: 10660907
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: May 26, 2020
    Assignee: CMP Development LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone Aqueous Compositions
    Publication number: 20200147109
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Application
    Filed: November 13, 2019
    Publication date: May 14, 2020
    Applicant: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Potassium phosphates composition for injection
    Patent number: 10632150
    Abstract: Disclosed herein is a sterile composition for injection comprised of potassium phosphates having no visible particulate. Also disclosed herein is a manufacturing process for the sterile composition and its use.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: April 28, 2020
    Assignee: CMP Development LLC
    Inventors: H. Greg Thomas, Richard LeVasseur, Jeffrey S. Kiel, Anthony Reid Pipho
  • Spironolactone aqueous compositions
    Patent number: 10624906
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: April 21, 2020
    Assignee: CMP Development LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone aqueous compositions
    Patent number: 10493083
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: December 3, 2019
    Assignee: CMP Development LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone Aqueous Compositions
    Publication number: 20170326158
    Abstract: Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
    Type: Application
    Filed: July 31, 2017
    Publication date: November 16, 2017
    Applicant: CMP Development LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone aqueous formulations
    Patent number: 9757394
    Abstract: Disclosed herein is a pharmaceutical composition, comprising: (a) spironolactone; (b) a xanthan gum; (c) an anti-foaming agent; (d) a preservative; (f) a dispersing agent; (g) a sweetening agent; (h) a flavoring agent; (i) optionally a buffer to maintain the pH of the pharmaceutical composition within a range described herein; and (j) a sufficient amount of a water vehicle.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: September 12, 2017
    Assignee: CMP DEVELOPMENT LLC
    Inventors: Anthony Pipho, Michael Paul DeHart
  • Spironolactone Aqueous Formulations
    Publication number: 20170119796
    Abstract: Disclosed herein is a pharmaceutical composition, comprising: (a) spironolactone; (b) a xanthan gum; (c) an anti-foaming agent; (d) a preservative; (f) a dispersing agent; (g) a sweetening agent; (h) a flavoring agent; (i) optionally a buffer to maintain the pH of the pharmaceutical composition within a range described herein; and (j) a sufficient amount of a water vehicle.
    Type: Application
    Filed: October 28, 2016
    Publication date: May 4, 2017
    Applicant: CMP Development LLC
    Inventors: Anthony Pipho, Michael Paul DeHart